X0306 4 2018-02-14 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001721442 Sabag Mark C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 0 1 0 0 EVP, Global Human Resources Ordinary Shares 2018-02-14 4 S 0 2050 18.45 D 44516.5421 D Ordinary Shares 2018-02-15 4 S 0 3000 20.52 D 41516.5421 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.43 to $18.47. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.54 to $20.50. The Ordinary Shares were sold in New Israeli Shekels. The prices have been converted to U.S. dollars using the daily representative rate of exchange published by the Bank of Israel on the transaction date. Reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Dov Bergwerk as attorney-in-fact for Mark Sabag 2018-02-20